论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhang Y, Ge Y, Wu X, Liu S
Received 7 January 2019
Accepted for publication 6 March 2019
Published 2 April 2019 Volume 2019:12 Pages 2421—2430
DOI https://doi.org/10.2147/OTT.S200625
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Ms Shreya Arora
Peer reviewer comments 2
Editor who approved publication: Dr William Cho
Abstract: The
prevalence of cancer remains high. With the improvement of diagnosis and
treatment level and the increase of cancer survivors after treatment, multiple
primary tumors are more common than before. The diagnosis and treatment of
synchronous multiple primary tumors is more complicated than that of single or
metachronous multiple tumors, and patients also suffer more. Because of the
different conditions of these patients, lack of large-scale clinical
observation data, it is necessary for clinicians to make realistic decisions on
the specific conditions of patients. It is a challenge for clinicians to apply
the advances of modern medicine to the diagnosis and treatment of such patients
so as to prolong their survival time and improve their quality of life. This
report describes the survival of an advanced elderly patient with lung,
prostate and bladder cancer after receiving targeted therapy-based
comprehensive treatment.
Keywords: advanced
synchronous triple primary malignancies